share_log

Clarus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James E. Thomas(0.2%),Thomas, McNerney & Partners, LLC(0.1%), etc.

Clarus Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-James E. Thomas(0.2%),Thomas, McNerney & Partners, LLC(0.1%)等

2022/04/21 20:43
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息